Astria Therapeutics
ATXS
ATXS
100 hedge funds and large institutions have $506M invested in Astria Therapeutics in 2024 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 39 increasing their positions, 27 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
38% less capital invested
Capital invested by funds: $811M → $506M (-$305M)
63% less call options, than puts
Call options by funds: $215K | Put options by funds: $577K
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
100
Holding in Top 10
1
Calls
$215K
Puts
$577K
Top Buyers
| 1 | +$19.6M | |
| 2 | +$15.8M | |
| 3 | +$6.14M | |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$5.74M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$4.88M |
Top Sellers
| 1 | -$22.9M | |
| 2 | -$18.3M | |
| 3 | -$13.8M | |
| 4 |
AG
Artal Group
Luxembourg
|
-$12.4M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$7.11M |